Zhongfeng Capsules protects against cerebral ischemia-reperfusion injury via mediating the phosphoinositide 3-kinase/Akt and toll-like receptor 4/nuclear factor kappa B signaling pathways by regulating neuronal apoptosis and inflammation.

MLA

Yan, Chunlu, et al. “Zhongfeng Capsules Protects against Cerebral Ischemia-Reperfusion Injury via Mediating the Phosphoinositide 3-Kinase/Akt and Toll-like Receptor 4/Nuclear Factor Kappa B Signaling Pathways by Regulating Neuronal Apoptosis and Inflammation.” Apoptosis : An International Journal on Programmed Cell Death, vol. 27, no. 7–8, Aug. 2022, pp. 561–76. EBSCOhost, https://doi.org/10.1007/s10495-022-01739-8.

APA

Yan, C., An, F., Wang, J., Shi, Y., Yuan, L., Lv, D., Zhao, Y., Liu, Y., & Wang, Y. (2022). Zhongfeng Capsules protects against cerebral ischemia-reperfusion injury via mediating the phosphoinositide 3-kinase/Akt and toll-like receptor 4/nuclear factor kappa B signaling pathways by regulating neuronal apoptosis and inflammation. Apoptosis : An International Journal on Programmed Cell Death, 27(7–8), 561–576. https://doi.org/10.1007/s10495-022-01739-8

Chicago

Yan, Chunlu, Fangyu An, Jiayu Wang, Yao Shi, Lingqing Yuan, Donghui Lv, Yanzhen Zhao, Yongqi Liu, and Yongfeng Wang. 2022. “Zhongfeng Capsules Protects against Cerebral Ischemia-Reperfusion Injury via Mediating the Phosphoinositide 3-Kinase/Akt and Toll-like Receptor 4/Nuclear Factor Kappa B Signaling Pathways by Regulating Neuronal Apoptosis and Inflammation.” Apoptosis : An International Journal on Programmed Cell Death 27 (7–8): 561–76. doi:10.1007/s10495-022-01739-8.